ArticleCardiology research and practice2022

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis.

Ze Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.